XML 60 R49.htm IDEA: XBRL DOCUMENT v3.21.2
Revenue (Details)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2021
USD ($)
units
Jun. 30, 2020
USD ($)
Jun. 30, 2021
USD ($)
units
Jun. 30, 2020
USD ($)
Dec. 31, 2020
USD ($)
Disaggregation of Revenue [Line Items]          
Emerging Markets total countries | units 20   20    
Net sales $ 3,077 $ 2,003 $ 5,829 $ 4,546  
Contract with Customer, Liability [Abstract]          
Contract with Customer, Liability 424   424   $ 395
Change in Contract with Customer, Liability [Abstract]          
Contract with Customer, Liability, Revenue Recognized 38   74    
United States          
Disaggregation of Revenue [Line Items]          
Net sales 1,800 1,118 3,386 2,607  
International [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 1,277 885 2,443 1,939  
Emerging Markets [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 359 268 676 542  
Global Endoscopy (Endo) Reporting Unit [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 551 348 1,050 790  
Global Endoscopy (Endo) Reporting Unit [Member] | United States          
Disaggregation of Revenue [Line Items]          
Net sales 316 190 596 445  
Global Endoscopy (Endo) Reporting Unit [Member] | International [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 235 158 454 345  
Global Urology (Uro) Reporting Unit [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 397 228 758 560  
Global Urology (Uro) Reporting Unit [Member] | United States          
Disaggregation of Revenue [Line Items]          
Net sales 285 162 542 400  
Global Urology (Uro) Reporting Unit [Member] | International [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 112 66 216 161  
Global CRM Reporting Unit [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 524 351 993 788  
Global CRM Reporting Unit [Member] | United States          
Disaggregation of Revenue [Line Items]          
Net sales 314 208 590 463  
Global CRM Reporting Unit [Member] | International [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 210 143 403 325  
Global Electrophysiology (EP) Reporting Unit [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 95 51 179 126  
Global Electrophysiology (EP) Reporting Unit [Member] | United States          
Disaggregation of Revenue [Line Items]          
Net sales 34 22 64 53  
Global Electrophysiology (EP) Reporting Unit [Member] | International [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 62 30 115 72  
Global Neuromodulation (NM) Reporting Unit [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 247 122 444 313  
Global Neuromodulation (NM) Reporting Unit [Member] | United States          
Disaggregation of Revenue [Line Items]          
Net sales 194 100 345 250  
Global Neuromodulation (NM) Reporting Unit [Member] | International [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 53 23 99 63  
Global Interventional Cardiology (IC) Reporting Unit [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 790 495 1,486 1,128  
Global Interventional Cardiology (IC) Reporting Unit [Member] | United States          
Disaggregation of Revenue [Line Items]          
Net sales 398 189 741 486  
Global Interventional Cardiology (IC) Reporting Unit [Member] | International [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 392 306 745 642  
Global Peripheral Interventions (PI) Reporting Unit [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 473 340 906 732  
Global Peripheral Interventions (PI) Reporting Unit [Member] | United States          
Disaggregation of Revenue [Line Items]          
Net sales 260 189 498 413  
Global Peripheral Interventions (PI) Reporting Unit [Member] | International [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 213 151 407 319  
Specialty Pharmaceuticals [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 0 68 13 109  
Specialty Pharmaceuticals [Member] | United States          
Disaggregation of Revenue [Line Items]          
Net sales 0 60 10 97  
Specialty Pharmaceuticals [Member] | International [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 0 8 4 12  
BSX Reportable Segments [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 3,077 1,935 5,816 4,437  
BSX Reportable Segments [Member] | United States          
Disaggregation of Revenue [Line Items]          
Net sales 1,800 1,058 3,376 2,510  
BSX Reportable Segments [Member] | EMEA [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 662 416 1,266 968  
BSX Reportable Segments [Member] | APAC [Member]          
Disaggregation of Revenue [Line Items]          
Net sales 520 410 994 819  
BSX Reportable Segments [Member] | Latin America and Canada [Member]          
Disaggregation of Revenue [Line Items]          
Net sales $ 95 $ 51 $ 180 $ 140